Cognitive Behavioral Psychopharmacology (eBook)

The Clinical Practice of Evidence-Based Biopsychosocial Integration

Mark Muse (Herausgeber)

eBook Download: PDF

2017
John Wiley & Sons (Verlag)
978-1-119-15257-6 (ISBN)

Infos

Outlines a comprehensive, evidence-based approach to coordinating psychopharmacological and psychotherapeutic treatments 

Cognitive Behavioral Psychopharmacology takes an evidence-based approach to demonstrating the advantages of biopsychosocial integration in interventions for the major psychiatric diagnoses. It is the first and only book to translate the current evidence for cognitive behavioral, psychosocial, and pharmacologic approaches to mental health disorders into clear guidance for clinical practice.

There is a burgeoning movement in mental health to acknowledge the entire person's functioning across physical, psychological and social spheres, and to integrate medical as well as psychological and social interventions to address the entire spectrum of presenting problems. This book bridges a gap in the professional mental health literature on the subject of standalone versus combined treatment approaches. It reviews the current state of integrative care, and makes a strong case that optimal outcomes are best achieved by an awareness of how and why the cognitive-behavioral aspects of prescribed medical and psychological interventions influence treatment. Each disorder-specific chapter is authored by a prescriber and psychotherapist team who consider all the evidence around treatments and combinations, providing outcome conclusions and concise tables of recommended front-line interventions.

• Provides a biopsychsocial perspective that integrates the medical, psychotherapeutic, family, and community aspects of the therapeutic process
• Brings together and compares the current evidence for and against treatments that combine psychopharmacology and cognitive behavioral psychotherapy for major psychiatric diagnoses
• Outlines an evidence-based approach to determining which combination of treatments is most appropriate for each of the major psychiatric diagnoses
• Describes, in a way that is accessible to both prescribers and therapists, when and how cognitive behavioral therapy can be integrated into pharmacotherapy

The book will appeal to a wide range of mental health professionals, including psychologists, psychiatrists, clinical social workers, licensed professional counselors, marriage and family therapists, and addictions counselors. It also will be of interest to primary care physicians and nurse practitioners who work side by side with mental health professionals.

MARK MUSE, EDD, PHD, ABPP, MP is licensed as a prescribing medical psychologist by the Louisiana State Board of Medical Examiners. He is past president of the Maryland Academy of Medical Psychologists, and is the author of numerous articles which have appeared in professional journals of psychology and medicine, as well as the books Introduction to Cognitive-Behavioral Therapy: Theoretical Foundations and Handbook of Clinical Psychopharmacology for Psychologists.

Inhalt

Cover 1
Title Page 5
Copyright 6
Contents 7
Notes on Contributors 9
Foreword 13
Preface 17
Chapter 1: Evidence-Based Biopsychosocial Treatment through the Integration of Pharmacotherapy and Psychosocial Therapy 21
Methodology 23
Results 24
The State of the Art of Clinical Research and its Derived Evidence-Based Practice Guidelines 29
Note 33
References 33
Chapter 2: Psychoses: Evidence-Based Integrated Biopsychosocial Treatment 37
Historical Perspective 39
Evidence-Based Findings 40
Level 1 Evidence: RCTs and Meta-analyses 41
Randomized Controlled Trials 41
Meta-Analyses 45
Level 2 Evidence: Less Well Controlled Trials or High Quality Cohort Studies 48
Level 3 Evidence: Case Controlled Studies and Reviews 48
Level 4 Evidence: Case Series, Case Reports, Panel of Experts, Institutional Guidelines 49
Practice Guidelines 50
Illustrative Case Studies 52
Final Observations 53
References 53
Chapter 3: Mood Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Major Depressive Disorder 59
Review of Depression Prevalence, Typical Course of Illness 60
Pharmacotherapy of Major Depressive Disorders 62
Historical Perspective 62
Comparisons Among Psychopharmacological Agents 64
Psychosocial Treatments of Major Depressive Disorder 66
Comparisons Among Various Psychotherapeutic Approaches 67
Combined Treatment of Major Depressive Disorder 69
Conclusions 73
Final Observations 73
Illustrative Case Studies 75
References 76
Chapter 4: Mood Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Bipolar Disorder 81
Diagnosis and Acute Management of Mania 83
Psychoeducation 83
Somatic Treatments for Acute Mania 86
Continuing Treatment 87
Psychosocial Interventions for Treatment Adherence 87
Bipolar Depression 91
Somatic Treatments for Bipolar Depression 91
Psychosocial Interventions for Bipolar Depression 92
Maintenance Phase 94
Medications for Relapse Prevention 94
Psychotherapy for Relapse Prevention 94
Summary 96
References 98
Chapter 5: Mood Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Dysthymia and Adjustment Disorder with Depression 105
Dysthymia 107
Pharmacotherapy with Dysthymia 108
Psychosocial Treatment of Dysthymia as a Stand-Alone or In Combination with Pharmacotherapy 110
Adjustment Disorder with Depression 114
Pharmacotherapy with Adjustment Disorders 115
Psychosocial Treatment of Adjustment Disorders 118
Combining Pharmacotherapy and Psychotherapy in Treating Adjustment Disorder with Depression 120
References 122
Chapter 6: Anxiety Disorders: Evidence-Based Integrated Biopsychosocial Treatment 127
A Brief History of the Treatment of Anxiety Disorders 127
Integrating Biopsychosocial Treatments of Anxiety Disorders 130
Generalized Anxiety Disorders 130
Specific Phobias 132
Social Anxiety Disorder 134
Panic Disorder 135
Posttraumatic stress disorder 137
Obsessive-Compulsive Disorder 138
Final Conclusions and Discussion 141
Notes 144
References 144
Chapter 7: Personality Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Borderline Personality Disorder 157
Psychopharmacologic Treatment of BPD 158
Antipsychotic Medications 159
Antidepressant Medications 161
Anticonvulsants 161
Lithium Carbonate 162
Benzodiazepines 162
Summary of Findings from Psychopharmacological Trials 162
Psychosocial Treatments of BPD 163
Psychodynamic Therapies 163
Cognitive-Behavioral Therapies 163
Systems Training for Emotional Predictability and Problem Solving 165
Mentalization-Based Therapy 165
Transference-Focused Psychotherapy 166
Conversational Model 166
Schema-Focused Therapy 166
Cognitive Analytical Therapy 166
Generalist Treatments and Supportive Care 166
Summary of Published Data on Psychological Treatment of BPD 167
Shorter Therapies for BPD 171
Role of Acute Mental Health Unit Hospitalization 172
Integrating Medication and Psychotherapy 173
Future Directions 173
Conclusions 174
References 176
Chapter 8: Sleep Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Insomnia 187
Historical Treatments for Insomnia 189
Pharmacologic Treatments for Insomnia 189
Benzodiazepines 189
Benzodiazepine Receptor Agonists (“Z-drugs”) 191
Melatonin And Melatonin Agonists 192
Orexin/Hypocretin Antagonists 193
Other Pharmacological Agents Used to Treat Insomnia 194
Psychosocial Therapy for Insomnia 196
Sleep Hygiene 196
Paradoxical Intention 196
Cognitive Therapy 197
Relaxation 197
Stimulus Control 197
Sleep Restriction 198
Integrating Biopsychosocial Treatments for Insomnia 199
Final Conclusions and Discussion 200
Notes 207
References 207
Chapter 9: Somatoform Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Chronic, Persistent, Nonmalignant Pain 213
Acute versus Chronic Pain 214
The Mind/Body Dilemma and Psychogenic Pain 215
The Biopsychosocial Model of Chronic Pain 215
Psychosocial Treatment for Pain 215
Evaluating Efficacy of Pain Treatments 220
Pharmacological Treatments for Chronic Pain 221
How Do We Achieve “Opioid Sparing”? 222
Efficacy of CBT for Chronic Pain 224
CBT Applications to Special Populations with Pain 227
Summary 228
Best-Practice Recommendations 229
Notes 230
References 231
Chapter 10: Eating Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Anorexia Nervosa, Bulimia and Binge Eating Disorder 237
Pharmacotherapy for Eating Disorders 239
Psychosocial Interventions in the Treatment of Eating Disorders 244
Cognitive-Behavioral Approaches 245
Systemic Family Therapy 246
Combined Therapy for Eating Disorders 247
References 253
Chapter 11: Childhood and Adolescent Disorders: Evidence-Based Integrated Biopsychosocial Treatment of ADHD and Disruptive Disorders 263
Attention Deficit Hyperactivity Disorder 263
Treatment Considerations 263
Pharmacotherapy for ADHD 264
Psychosocial Therapies for ADHD 266
Combined Treatments for ADHD 268
ADHD and Co-Morbid Disorders 269
Oppositional Defiant Disorder 271
Pharmacotherapy for ODD 271
Psychosocial Therapies for ODD 272
Combined Treatments for ODD 275
ODD and Co-Morbid Disorders 276
Challenges to Treatment Interventions 278
Conduct Disorder 278
Treatment Considerations 278
Pharmacotherapy for CD 279
Psychosocial Therapies for CD 283
Combined Treatment of Conduct Disorder 286
CD and Co-morbid Disorders 288
Challenges to Integrated Treatment Interventions with CD 288
Recommendations for the Treatment of ADHD and Disruptive Disorders 289
Note 292
References 292
Chapter 12: Geriatric Disorders: Evidence-Based Integrated Biopsychosocial Treatment of Depression, Dementia, and Dementia-Related Disorders in the Elderly 305
Late-Life Depression 305
Pharmacotherapy with Late-Life Depression 306
Psychosocial Therapy with Late-Life Depression 308
Pharmacotherapy and Psychosocial Therapy as Monotherapies and in Combination in Late-Life Depression 310
Practice Guidelines for the Treatment of Late-Life Depression 311
Cognitive Deficits Associated with Dementia 311
Pharmacotherapy to Remediate Cognitive Deficits of Dementia 312
Psychosocial Therapy to Remediate Cognitive Deficits of Dementia 315
Practice Guidelines to Remediate Cognitive Deficits of Dementia 317
Co-morbid Conditions Associated with Dementia 317
Depression Concomitant with Dementia 317
Pharmacotherapy of Depression Concomitant with Dementia 318
Psychosocial Therapy of Depression Concomitant with Dementia 319
Practice Guidelines for Depression Concomitant with Dementia 320
Psychotic symptoms Concomitant with Dementia 320
Pharmacotherapy of Psychotic Symptoms Concomitant with Dementia 321
Psychosocial Therapy of Psychotic Symptoms Concomitant with Dementia 322
Practice Guidelines for Psychotic Symptoms Concomitant with Dementia 322
Behavioral Disturbances Concomitant with Dementia 323
Pharmacotherapy of Behavioral Disturbances Concomitant with Dementia 324
Psychosocial Therapy of Behavioral Disturbances Concomitant with Dementia 326
Practice Guidelines for Behavioral Disturbances Concomitant with Dementia 327
Conclusions 327
References 331
Chapter 13: Behaviorally Prescribed Psychopharmacology: Beyond Combined Treatments to Coordinated Integrative Therapy 345
Cognitive-Behavioral Learning Theory and Acquired Psychopathology 347
Reinforcing and Aversive Properties of Pharmacological Agents 349
Operant Reinforcers 352
Respondent Conditioners 354
Social/Cognitive Reinforcers/Conditioners 355
Cognitive Enhancers in Classical, Instrumental and Social Therapeutic Learning 356
Unintended Conditioning Outcomes of Medication Side Effects 356
Targeting Symptoms with Specific Cognitive-Behavioral Psychopharmacology Interventions 358
Anxiety 358
Depression 360
Psychosis 361
Other syndromes 363
Conclusion 367
Notes 368
References 370
Index 383
EULA 394

Rezensionen

"Cognitive Behavioral Psychopharmacology: The Clinical Pracrice of Evidence-Based Biopsychosocial Integration represents a significant advance for clinicians seeking to combine evidence-based pharmacological and psychotherapeutic interventions. The contributors represent an impressive array of experts in psychology and psychiatry, and provide an excellent and current synopsis of combined interventions in the various specialty areas of behavioral health". -- Morgan T. Sammons, PhD, ABPP, Executive Officer, National Register of Health Service Psychologists

Produkt-Details

• Erscheint lt. Verlag: 12.10.2017
• Sprache: englisch
• Themenwelt: Geisteswissenschaften ► Psychologie ► Klinische Psychologie
• Themenwelt: Medizin / Pharmazie ► Gesundheitsfachberufe
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie
• Schlagworte: biopsychosocial interventions • biopsychosocial interventions for psychoses • bipolar disorder biopsychosocial treatments • Clinical psychology • cognitive behavioral psychopharmacology • Cognitive Behavioral Therapy • Cognitive behavioral therapy (CBT) • combined psychopharmacology and psychotherapy • evidence-based biopsychosocial interventions • integrated biopsychosocial treatment for depression • integrated biopsychosocial treatment of adhd • integrated biopsychosocial treatment of adjustment disorder • integrated biopsychosocial treatment of anxiety disorders • integrated biopsychosocial treatment of chronic, persistent, non-malignant pain • integrated biopsychosocial treatment of disruptive disorder • integrated biopsychosocial treatment of dysthymia • integrated biopsychosocial treatment of eating disorders • integrated biopsychosocial treatment of geriatric disorders</p> • integrated biopsychosocial treatment of personality disorders • integrated biopsychosocial treatment of sleep disorders • integrated biopsychosocial treatment of somatoform disorders • integrated biopsychosocial treatments for mood disorders • integrating psychiatric drugs and psychotherapy • Klinische Psychologie • Kognitive Verhaltenstherapie • <p>combined treatment in mental health • Medical Science • Medizin • Psychiatrie • Psychiatry • Psychologie • Psychology • psychopharmacological interventions • Psychopharmacology • Psychotherapie • Psychotherapie u. Beratung • psychotherapy • Psychotherapy & Counseling • standalone treatment vs combined treatment in psychiatry
• ISBN-10: 1-119-15257-7 / 1119152577
• ISBN-13: 978-1-119-15257-6 / 9781119152576